Search Results - "Pawlyn C"

RWD160 Time to Treatment Initiation and Patient Characteristics in Newly Diagnosed Multiple Myeloma Patients With and Without Transplant: Real-World Evidence Using Big Data From England.

Authors: Pawlyn, C. Broe, A. Lay-Flurrie, S. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS535-S535. 1p.

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.

Authors: Costa, L. J. Bahlis, N. J. Perrot, A. et al.

Source: New England Journal of Medicine. 2/19/2026, Vol. 394 Issue 8, p739-752. 14p.

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.

Authors: Richardson, P. G. Trudel, S. Popat, R. et al.

Source: New England Journal of Medicine. 9/14/2023, Vol. 389 Issue 11, p1009-1022. 14p.

The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.

Authors: Park H Robinson J Flanagan C et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 7-16. Date of Electronic Publication: 2025 Sep 29.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN).

Authors: Ludwig H Terpos E Gay F et al.

Source: American journal of hematology [Am J Hematol] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.

Authors: Hall A Croft J Walker K et al.

Source: British journal of haematology [Br J Haematol] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Authors: Mina R Beksac M Rodríguez-Otero P et al.

Corporate Authors: Mina R Beksac M Rodríguez-Otero P et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Jun 13. Date of Electronic Publication: 2026 Jun 13.

Publication Type: Journal Article

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma.

Authors: Messiou C Porta N Koh DM et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Jul 17; Vol. 15 (1), pp. 122. Date of Electronic Publication: 2025 Jul 17.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.

Authors: Li Y Wilson A Chrisochoidou Y et al.

Source: Haematologica [Haematologica] 2026 Feb 12. Date of Electronic Publication: 2026 Feb 12.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Authors: Bertuglia G Seneca E Corbett T et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Feb; Vol. 26 (2), pp. e188-e200.e5. Date of Electronic Publication: 2025 Nov 10.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry.

Authors: Babu EM Fermahan S Bowen J et al.

Source: Scientific reports [Sci Rep] 2026 Jan 26; Vol. 16 (1), pp. 4055. Date of Electronic Publication: 2026 Jan 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.

Authors: Einsele H Moreau P Bahlis N et al.

Source: Advances in therapy [Adv Ther] 2026 Jan; Vol. 43 (1), pp. 333-355. Date of Electronic Publication: 2025 Nov 28.

Publication Type: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Authors: Beer SA Cairns DA Pawlyn C et al.

Source: Blood [Blood] 2025 Nov 27; Vol. 146 (22), pp. 2670-2680.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group.

Authors: Moore S Miller H Parrish C et al.

Source: British journal of haematology [Br J Haematol] 2025 Nov; Vol. 207 (5), pp. 1789-1801. Date of Electronic Publication: 2025 Sep 03.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process

Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study.

Authors: Abdallah N Mian H Seow H et al.

Source: American journal of hematology [Am J Hematol] 2025 Nov; Vol. 100 (11), pp. 2144-2149. Date of Electronic Publication: 2025 Aug 29.

Publication Type: Letter

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.

Authors: Pawlyn C Schjesvold FH Cairns DA et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Aug 12; Vol. 14 (1), pp. 134. Date of Electronic Publication: 2024 Aug 12.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma.

Authors: Bird S Pawlyn C

Source: Nature [Nature] 2025 Sep; Vol. 645 (8079), pp. 44-45.

Publication Type: News

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; In Process

The Role of CELMoD Agents in Multiple Myeloma.

Authors: van de Donk NWCJ Bahlis NJ Pawlyn C et al.

Source: OncoTargets and therapy [Onco Targets Ther] 2025 Aug 27; Vol. 18, pp. 921-933. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE

The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.

Authors: Hwang A Hayden P Pawlyn C et al.

Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1159-1175. Date of Electronic Publication: 2024 Feb 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Authors: Giles HV Drayson MT Kishore B et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Mar 18; Vol. 14 (1), pp. 50. Date of Electronic Publication: 2024 Mar 18.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE